Table: Delta-Fly Pharma -2018/19 parent results

Delta-Fly Pharma

15/05/2019 08:00

May 15 (Reuters)- 
          Delta-Fly Pharma, Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended      Year ended        Year to         NEXT   
               Mar 31, 2019    Mar 31, 2018     Mar 31, 2020      YEAR     
                  LATEST         YEAR-AGO         COMPANY        COMPANY   
                 RESULTS          RESULTS         FORECAST     H1 FORECAST 
  Sales                           150 mln                                  
               (-100.0 pct)     (-83.4 pct)                                
  Operating    loss 592 mln    loss 243 mln      loss 1.07                 
  Recurring    loss 671 mln    loss 244 mln      loss 1.07                 
  Net          loss 673 mln    loss 246 mln      loss 1.07                 
  EPS        loss 170.16 yen  loss 71.20 yen  loss 244.85 yen              
  Ann Div          NIL              NIL             NIL                    
  -Q2 Div          NIL              NIL             NIL                    
  -Q4 Div          NIL              NIL             NIL                    
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T